Pillai Goonaseelan Colin, Mentré France, Steimer Jean-Louis
Modeling and Simulation, Novartis Pharma AG, Basel, Switzerland.
J Pharmacokinet Pharmacodyn. 2005 Apr;32(2):161-83. doi: 10.1007/s10928-005-0062-y. Epub 2005 Nov 7.
Few scientific contributions have made significant impact unless there was a champion who had the vision to see the potential for its use in seemingly disparate areas-and who then drove active implementation. In this paper, we present a historical summary of the development of non-linear mixed effects (NLME) modeling up to the more recent extensions of this statistical methodology. The paper places strong emphasis on the pivotal role played by Lewis B. Sheiner (1940-2004), who used this statistical methodology to elucidate solutions to real problems identified in clinical practice and in medical research and on how he drove implementation of the proposed solutions. A succinct overview of the evolution of the NLME modeling methodology is presented as well as ideas on how its expansion helped to provide guidance for a more scientific view of (model-based) drug development that reduces empiricism in favor of critical quantitative thinking and decision making.
很少有科学贡献能产生重大影响,除非有一位倡导者,他有远见,能看到其在看似不同领域的应用潜力,然后推动积极实施。在本文中,我们对非线性混合效应(NLME)建模的发展进行了历史总结,直至这种统计方法的最新扩展。本文特别强调了刘易斯·B·谢纳(1940 - 2004)所起的关键作用,他运用这种统计方法阐明了临床实践和医学研究中发现的实际问题的解决方案,以及他如何推动所提出解决方案的实施。本文还简要概述了NLME建模方法的演变,以及其扩展如何有助于为更科学的(基于模型的)药物开发观点提供指导,这种观点减少了经验主义,转而支持批判性定量思维和决策。